Type-2 gastric carcinoids occur in the presence of gastrinoma, primarily in those with MEN-1/ZES, rarely in uncomplicated sporadic ZES, comprise 5%–6% of gastric carcinoids, are gastrin-dependent, and malignant in 10%–30% of cases [11]. This evidence concerns the gene GAST and gastrin-producing neuroendocrine tumor.